29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Angelman syndrome is a rare neurodevelopmental disorder characterized by severe mental retardation, speech impairment, ataxic gait, seizures, and a distinctively happy personality. First described by Harry Angelman in 1965, the condition has been reported worldwide, but until now, not from Iraq. This book presents the first documented Iraqi case of Angelman syndrome, emphasizing its clinical, radiological, and therapeutic aspects. This case described in this book reinforces the diagnostic value of combining detailed clinical observation with neuroimaging in recognizing Angelman syndrome. It…mehr

Produktbeschreibung
Angelman syndrome is a rare neurodevelopmental disorder characterized by severe mental retardation, speech impairment, ataxic gait, seizures, and a distinctively happy personality. First described by Harry Angelman in 1965, the condition has been reported worldwide, but until now, not from Iraq. This book presents the first documented Iraqi case of Angelman syndrome, emphasizing its clinical, radiological, and therapeutic aspects. This case described in this book reinforces the diagnostic value of combining detailed clinical observation with neuroimaging in recognizing Angelman syndrome. It also highlights the potential role of lamotrigine and neurotrophic agents in improving seizure control and cognitive function. Importantly, this report marks the first identification of Angelman syndrome in Iraq, underscoring the growing need for genetic and neurodevelopmental diagnostic services in the region.
Autorenporträt
Aamir Jalal Al-Mosawi is advisor doctor at the National Training and Development Center of the Iraqi Ministry of Health and Baghdad Medical City. He was the Head of Iraq Headquarter of Copernicus Scientists International Panel (2006-October, 2020). He is also member of the advisory council, the International Association of Medical Colleges (IAMC).